维生素B6通过抑制大动脉外细胞基质的病态重塑来减弱大动脉剖析
Ru Chen1, Dongkai Gao1, Wuyi Ban1
1College of Pharmacy and Food, Southwest Minzu University, Chengdu, China.
Pakistan journal of pharmaceutical sciences
|February 1, 2026
概括
维生素B6 (B6) 补充剂在治疗大动脉解剖 (AD) 中表现有前途. 维生素B6通过减少氧化应激和保持其结构来保护大动脉,可能减缓疾病的进展.
科学领域:
- 血管生物学 血管生物学
- 营养科学 营养科学
- 生物化学 生化学
背景情况:
- 大动脉解剖 (AD) 是一种危及生命的疾病,死亡率高.
- 维生素B6 (B6) 对于生理功能至关重要,并可能防止血管疾病,但其在阿尔茨海默病中的作用尚不清楚.
研究的目的:
- 在大动脉解剖 (AD) 的小鼠模型中研究维生素B6 (B6) 的治疗作用和机制.
主要方法:
- 建立了一个β-aminopropionitrile (BAPN) 诱导的AD小鼠模型.
- 服用B6 (50毫克/公斤/天) 四周,监测存活率和体重.
- 评估了大动脉形态,弹性质完整性,细胞外矩阵 (ECM) 组件和氧化应激标志物 (SOD,MDA).
主要成果:
- 维生素B6补充剂显著降低了AD发病率和改善了生存率.
- 组织学分析显示,通过B6治疗,大动脉结构得到保存,弹性质降解减少.
- 乙6证明了抗氧化作用,减轻氧化应激,抑制光滑肌肉细胞表型切换和ECM降解.
结论:
- 维生素B6 (B6) 治疗可以通过抗氧化作用保护大动脉细胞外基质 (ECM) 来减缓大动脉解剖 (AD) 的进展.
- 这些发现表明B6补充剂是AD预防和治疗的潜在治疗策略.
相关概念视频
The Extracellular Matrix
89.0K
Overview
89.0K
The Extracellular Matrix
12.2K
Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
12.2K
Aortic Regurgitation I: Introduction
609
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
609
Extracellular Matrix
5.4K
Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
5.4K
Aortic Regurgitation III: Medical Management
443
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
443
Aortic Regurgitation IV: Nursing Management
319
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
319


